安徽省部分医院室间质量评价样品现场检测结果分析

Analysis of the On-spot Inspection Results of Specimens from External Quality Assessments in Hospitals of Anhui

目的考核市级医院、县级医院及民营医院的临床常规化学、凝血试验、乙丙肝抗原抗体检测三个大常规专业项目的现场检测能力。方法利用安徽省临床检验中心2016年和2017年室间质评活动的同批次样本,设计各专业考核样本盘,开展现场监督检测,结果上传系统网络平台,以同批次全省分组大数据的允许范围为判定标准,按照国际通用的评价方案,分别考核各项目中各类医院的检测能力。结果临床常规化学、凝血试验、乙丙肝抗原抗体检测三个专业中,市级医院的平均PT得分为95.63、99.63、92.50,及格率情况分别为100%、100%、87.5%;县级医院平均PT得分94.46、99.50、82.66,及格率分别为96.97%、100%、68.75%;民营医院平均PT得分89.50、90.81、82.50,及格率分别为93.75%、93.75%、56.25%。结论三个常规专业的平均得分都在80分以上,按照评价标准,说明整体检测能力合格,其中市级医院高于县级,县级医院高于民营;三类医院中,临床常规化学、乙丙肝抗原抗体检测专业的检测能力较好,凝血试验检测能力有待进一步加强。

Objective To evaluate the on-spot inspection capabilities of clinical routine chemistry and coagulation tests,and hepatitis B and C immunoassays in municipal,county and private hospitals. Methods Specimens were collected from 2016 to 2017 and external quality assessments of Anhui Provincial Center for Clinical Laboratories were used to design sample examination panels,then on-spot supervision and inspection were carried out. The results were uploaded to the network platform,the allowable range of big data was used as the criterion to evaluate the testing capabilities of the hospitals in different projects according to the international evaluation scheme. Results In clinical routine chemistry tests,coagulation tests and hepatitis B and C immunoassays,the average PT scores in municipal hospitals were 95.63,99.63 and 92.50 and the passing rates were 100%,100% and 87.5%,respectively. The averages PT scores of county hospitals were 94.46,99.50 and 82.66 with the passing rates of 96.97%,100% and 68.75%,respectively. The average PT scores of private hospitals were 89.50,90.81 and 82.50 with the passing rates of 93.75%,93.75% and 56.25%,respectively. ConclusionThe average PT score of the three clinical examinations was found to be more than 80 and the overall testing ability is qualified but higher in city hospitals than in county and private hospitals successively. Among the three types of hospitals,the testing capabilities of clinical routine chemistry analysis tests and hepatitis B and C immunoassays are in good state but coagulation tests need to be improved.